385112003: Conventional release cutaneous powder (dose form)

SNOMED CT Concept\Qualifier value (qualifier value)\Pharmaceutical dose form (dose form)\Cutaneous dose form\Cutaneous powder

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1479374014 Cutaneous powder en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3559622012 Conventional release cutaneous powder (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3559623019 Conventional release cutaneous powder en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

32441000188113 poudre pour application cutanée fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Cutaneous powder	Is a	forme pharmaceutique pour usage transdermique et/ou cutané	false	Inferred relationship	Some
Cutaneous powder	Is a	Drug powder	false	Inferred relationship	Some
Cutaneous powder	Is a	Cutaneous dose form	true	Inferred relationship	Some
Cutaneous powder	Has dose form administration method (attribute)	A method of administration of a dose form by placing or spreading on a body surface.	true	Inferred relationship	Some
Cutaneous powder	Dose form intended site describes the general anatomic location that the dose form has been formulated for administration to or at. The intended site is not intended to describe a precise site or route of administration. For example, eye drops (prepared for ocular intended site) are subject to pharmacopoeial standards for pH, and sterility.	An intended site for a dose form that is for administration by application to the skin, cutaneous wounds, nails or hair.	true	Inferred relationship	Some
Cutaneous powder	Has dose form release characteristic (attribute)	A release characteristic where a dose form displays a rate and time of release of the active substance(s) in the dose form based on their intrinsic properties.	true	Inferred relationship	Some
Cutaneous powder	Has basic dose form (attribute)	A solid dose form consisting of one or more particulate solids of varying degrees of fineness.	true	Inferred relationship	Some
Cutaneous powder	Has dose form transformation (attribute)	No transformation	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Cutaneous powder spray	Is a	False	Cutaneous powder	Inferred relationship	Some
Nystatin 100 unit/mg cutaneous powder	Has manufactured dose form	True	Cutaneous powder	Inferred relationship	Some
Streptokinase+streptodornase 100,000/25,000units topical powder	Has manufactured dose form	False	Cutaneous powder	Inferred relationship	Some
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug)	Has manufactured dose form	True	Cutaneous powder	Inferred relationship	Some
Undecylenic acid 50 microgram/mg and zinc undecylenate 200 microgram/mg cutaneous powder	Has manufactured dose form	True	Cutaneous powder	Inferred relationship	Some
Tolnaftate 10 mg/g cutaneous powder	Has manufactured dose form	True	Cutaneous powder	Inferred relationship	Some
Mafenide acetate 5% powder	Has manufactured dose form	False	Cutaneous powder	Inferred relationship	Some
Chlorhexidine diacetate 10 mg/g cutaneous powder	Has manufactured dose form	True	Cutaneous powder	Inferred relationship	Some
Product containing precisely clotrimazole 10 milligram/1 gram conventional release cutaneous powder (clinical drug)	Has manufactured dose form	True	Cutaneous powder	Inferred relationship	Some
Salicylic acid+boric acid 3%/5% conventional release cutaneous powder	Has manufactured dose form	False	Cutaneous powder	Inferred relationship	Some
Product containing precisely salicylic acid 50 microgram/1 milligram and zinc oxide 200 microgram/1 milligram conventional release cutaneous powder (clinical drug)	Has manufactured dose form	True	Cutaneous powder	Inferred relationship	Some
Miconazole nitrate 20 mg/g cutaneous powder	Has manufactured dose form	True	Cutaneous powder	Inferred relationship	Some
Calcium carbonate 900 mg/g cutaneous powder	Has manufactured dose form	True	Cutaneous powder	Inferred relationship	Some
Calcium undecylenate 100 mg/g cutaneous powder	Has manufactured dose form	True	Cutaneous powder	Inferred relationship	Some
Product containing precisely povidone iodine 50 milligram/1 gram conventional release cutaneous powder (clinical drug)	Has manufactured dose form	True	Cutaneous powder	Inferred relationship	Some
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder	Has manufactured dose form	True	Cutaneous powder	Inferred relationship	Some
Product containing precisely zinc undecylenate 100 milligram/1 gram conventional release cutaneous powder (clinical drug)	Has manufactured dose form	True	Cutaneous powder	Inferred relationship	Some
Product containing precisely econazole nitrate 10 milligram/1 gram conventional release cutaneous powder (clinical drug)	Has manufactured dose form	True	Cutaneous powder	Inferred relationship	Some

This concept is not in any reference sets